Presentation is loading. Please wait.

Presentation is loading. Please wait.

Clinical Microbiology and Infection

Similar presentations


Presentation on theme: "Clinical Microbiology and Infection"— Presentation transcript:

1 Clinical Microbiology and Infection
Oral presentations  Clinical Microbiology and Infection  Volume 17, Pages S1-S107 (May 2011) DOI: /j x Copyright © Terms and Conditions

2 Clinical Microbiology and Infection 2011 17, S1-S107DOI: (10. 1111/j
Clinical Microbiology and Infection  , S1-S107DOI: ( /j x) Copyright © Terms and Conditions

3 Figure 1 In vivo activity of ClyS ointment vs. placebo or mupirocin on tape-stripped mice infected with S. aureus 8325–4 or MRSA MW2. Topical treatrnents included Aquaphor® (control), 10% ClyS binding domain in Aquaphor® (placebo), 10% wt/wt ClyS in Aquaphor®, and 2% mupirocin. The median value of the data for each group is shown as a horizontal bar; each sphere represents one mouse. No statistical significance was seen between untreated, control, and placebo groups. Statistical significance (p < ) was noted between untreated/control/placebo and ClyS groups with a three log drop in bacteria recovered (CFUs). Statistical difference (p = 0.001) was noted between ClyS and mupirocin treated groups, with a one log drop difference between them. Figure is representative of experiments using S. aureus strain 8325–4 or MRSA strain MW2. Clinical Microbiology and Infection  , S1-S107DOI: ( /j x) Copyright © Terms and Conditions

4 Fig. 1 Percent of cultures from the five high touch sites that were negative for aerobic growth after decontamination with the HPV and UVC process. Clinical Microbiology and Infection  , S1-S107DOI: ( /j x) Copyright © Terms and Conditions

5 Clinical Microbiology and Infection 2011 17, S1-S107DOI: (10. 1111/j
Clinical Microbiology and Infection  , S1-S107DOI: ( /j x) Copyright © Terms and Conditions

6 Clinical Microbiology and Infection 2011 17, S1-S107DOI: (10. 1111/j
Clinical Microbiology and Infection  , S1-S107DOI: ( /j x) Copyright © Terms and Conditions

7 Clinical Microbiology and Infection 2011 17, S1-S107DOI: (10. 1111/j
Clinical Microbiology and Infection  , S1-S107DOI: ( /j x) Copyright © Terms and Conditions

8 Figure 1 Implementation of policy elements covered by the survey questionnai re Clinical Microbiology and Infection  , S1-S107DOI: ( /j x) Copyright © Terms and Conditions

9 Clinical Microbiology and Infection 2011 17, S1-S107DOI: (10. 1111/j
Clinical Microbiology and Infection  , S1-S107DOI: ( /j x) Copyright © Terms and Conditions

10 Clinical Microbiology and Infection 2011 17, S1-S107DOI: (10. 1111/j
Clinical Microbiology and Infection  , S1-S107DOI: ( /j x) Copyright © Terms and Conditions

11 Clinical Microbiology and Infection 2011 17, S1-S107DOI: (10. 1111/j
Clinical Microbiology and Infection  , S1-S107DOI: ( /j x) Copyright © Terms and Conditions

12 Clinical Microbiology and Infection 2011 17, S1-S107DOI: (10. 1111/j
Clinical Microbiology and Infection  , S1-S107DOI: ( /j x) Copyright © Terms and Conditions

13 Figure 1 Pneumococcal vaccination and invasive pneumococcal disease 2002–2009. Clinical Microbiology and Infection  , S1-S107DOI: ( /j x) Copyright © Terms and Conditions

14 Clinical Microbiology and Infection 2011 17, S1-S107DOI: (10. 1111/j
Clinical Microbiology and Infection  , S1-S107DOI: ( /j x) Copyright © Terms and Conditions

15 Clinical Microbiology and Infection 2011 17, S1-S107DOI: (10. 1111/j
Clinical Microbiology and Infection  , S1-S107DOI: ( /j x) Copyright © Terms and Conditions

16 Clinical Microbiology and Infection 2011 17, S1-S107DOI: (10. 1111/j
Clinical Microbiology and Infection  , S1-S107DOI: ( /j x) Copyright © Terms and Conditions

17 Clinical Microbiology and Infection 2011 17, S1-S107DOI: (10. 1111/j
Clinical Microbiology and Infection  , S1-S107DOI: ( /j x) Copyright © Terms and Conditions

18 Clinical Microbiology and Infection 2011 17, S1-S107DOI: (10. 1111/j
Clinical Microbiology and Infection  , S1-S107DOI: ( /j x) Copyright © Terms and Conditions

19 Clinical Microbiology and Infection 2011 17, S1-S107DOI: (10. 1111/j
Clinical Microbiology and Infection  , S1-S107DOI: ( /j x) Copyright © Terms and Conditions

20 Clinical Microbiology and Infection 2011 17, S1-S107DOI: (10. 1111/j
Clinical Microbiology and Infection  , S1-S107DOI: ( /j x) Copyright © Terms and Conditions

21 Clinical Microbiology and Infection 2011 17, S1-S107DOI: (10. 1111/j
Clinical Microbiology and Infection  , S1-S107DOI: ( /j x) Copyright © Terms and Conditions

22 Clinical Microbiology and Infection 2011 17, S1-S107DOI: (10. 1111/j
Clinical Microbiology and Infection  , S1-S107DOI: ( /j x) Copyright © Terms and Conditions

23 Clinical Microbiology and Infection 2011 17, S1-S107DOI: (10. 1111/j
Clinical Microbiology and Infection  , S1-S107DOI: ( /j x) Copyright © Terms and Conditions


Download ppt "Clinical Microbiology and Infection"

Similar presentations


Ads by Google